ACM
ACT Capital Management Portfolio holdings
AUM
$72.5M
This Quarter Return
-14.88%
1 Year Return
-33.17%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$138M
AUM Growth
+$138M
(-28%)
Cap. Flow
-$11.4M
Cap. Flow
% of AUM
-8.27%
Top 10 Holdings %
Top 10 Hldgs %
60.84%
Holding
122
New
14
Increased
15
Reduced
28
Closed
30
Top Buys
| 1 |
Adtran
ADTN
|
$2.63M |
| 2 |
Meta Platforms (Facebook)
META
|
$2.52M |
| 3 |
Vir Biotechnology
VIR
|
$2.43M |
| 4 |
AirSculpt Technologies
AIRS
|
$1.75M |
| 5 |
Stratasys
SSYS
|
$1.62M |
Top Sells
| 1 |
TRIL
Trillium Therapeutics Inc.
TRIL
|
$8.18M |
| 2 |
Affirm
AFRM
|
$2.92M |
| 3 |
NUAN
Nuance Communications, Inc.
NUAN
|
$2.06M |
| 4 |
Upstart Holdings
UPST
|
$1.74M |
| 5 |
Atara Biotherapeutics
ATRA
|
$1.7M |
Sector Composition
| 1 | Healthcare | 82.21% |
| 2 | Technology | 6.77% |
| 3 | Communication Services | 4.59% |
| 4 | Consumer Discretionary | 2.09% |
| 5 | Energy | 2.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
STAAR Surgical
STAA
$1.36B
| $23.6M | 17.04% |
258,100
-10,100
| -4% | -$922K |
|
2
Arcturus Therapeutics
ARCT
$462M
| $17.7M | 12.83% |
479,400
+24,100
| +5% | +$892K |
|
3
Arrowhead Research
ARWR
$3.05B
| $14M | 10.09% |
210,500
+16,500
| +9% | +$1.09M |
|
4
Clearside Biomedical
CLSD
$28.9M
| $6.83M | 4.94% |
2,483,500
+16,000
| +0.6% | +$44K |
|
5
Aurinia Pharmaceuticals
AUPH
$1.58B
| $4.31M | 3.12% |
188,500
+8,500
| +5% | +$194K |
|
6
Krystal Biotech
KRYS
$4.27B
| $4.13M | 2.98% |
59,000
+19,000
| +48% | +$1.33M |
|
7
IDEAYA Biosciences
IDYA
$2.15B
| $4.1M | 2.97% |
173,500
| – | – |
|
8
fuboTV
FUBO
$1.21B
| $3.58M | 2.59% |
230,500
-23,200
| -9% | -$360K |
|
9
Natera
NTRA
$23.1B
| $3.03M | 2.19% |
32,400
+6,500
| +25% | +$607K |
|
10
United Therapeutics
UTHR
$13.8B
| $2.92M | 2.11% |
13,500
+3,000
| +29% | +$648K |
|
|
11
Adtran
ADTN
$751M
| $2.63M | 1.9% |
+115,000
| New | +$2.63M |
|
|
12
Meta Platforms (Facebook)
META
$1.86T
| $2.52M | 1.82% |
+7,500
| New | +$2.52M |
|
|
13
Vir Biotechnology
VIR
$686M
| $2.43M | 1.76% |
+58,000
| New | +$2.43M |
|
14
INmune Bio
INMB
$54M
| $2.35M | 1.7% |
230,500
-44,500
| -16% | -$454K |
|
|
ICAD
15
DELISTED
iCAD Inc
ICAD
| $2.33M | 1.69% |
324,100
+99,600
| +44% | +$717K |
|
|
16
Stratasys
SSYS
$906M
| $2.29M | 1.66% |
93,500
+66,000
| +240% | +$1.62M |
|
|
AWH
17
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
| $1.77M | 1.28% |
1,000,000
-130,720
| -12% | -$231K |
|
|
18
AirSculpt Technologies
AIRS
$403M
| $1.75M | 1.26% |
+101,500
| New | +$1.75M |
|
19
enVVeno Medical
NVNO
$15.4M
| $1.73M | 1.25% |
262,500
| – | – |
|
|
AFMD
20
DELISTED
Affimed
AFMD
| $1.71M | 1.23% |
308,800
+27,500
| +10% | +$152K |
|
21
Inhibikase Therapeutics
IKT
$134M
| $1.58M | 1.14% |
1,076,500
+66,500
| +7% | +$97.7K |
|
22
PubMatic
PUBM
$396M
| $1.53M | 1.11% |
+45,000
| New | +$1.53M |
|
23
Chevron
CVX
$324B
| $1.47M | 1.06% |
12,500
-3,500
| -22% | -$411K |
|
24
Global E Online
GLBE
$5.68B
| $1.43M | 1.03% |
+22,500
| New | +$1.43M |
|
|
MYOV
25
DELISTED
Myovant Sciences Ltd.
MYOV
| $1.32M | 0.96% |
85,000
| – | – |
|